Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account.
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an EmailPlease send an email to stoptrade@acml.infrom your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07965081981 Ext: 4 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us,and we appreciate your cooperation in maintaining the integrity of your trading account.
Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 2315, up 2.18% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.19% on the day, quoting at 22705.75. The Sensex is at 73339.6, down 0.35%. Glenmark Pharmaceuticals Ltd has dropped around 5.18% in last one month.
Meanwhile, Nifty Pharma index of which Glenmark Pharmaceuticals Ltd is a constituent, has dropped around 1.54% in last one month and is currently quoting at 26267.25, up 0.96% on the day. The volume in the stock stood at 2.34 lakh shares today, compared to the daily average of 6.53 lakh shares in last one month.
The benchmark November futures contract for the stock is quoting at Rs 2322.7, up 1.7% on the day. Glenmark Pharmaceuticals Ltd is up 25.59% in last one year as compared to a 12.85% fall in NIFTY and a 18.23% fall in the Nifty Pharma index.
The PE of the stock is 43.86 based on TTM earnings ending June 26.